Advanced Computing in the Age of AI | Friday, March 29, 2024

pharmaceutical

Insilico, Pfizer Join AI Forces on Drug Discovery

Previous attempts to apply AI to drug discovery have yielded mixed results. For example, IBM ended sales last year of its Watson AI software used by pharmaceutical firms for ...Full Article

Drug Developers Enlist Google Cloud HPC in the Fight Against ALS

Within the haystack of a lethal disease such as ALS (amyotrophic lateral sclerosis / Lou Gehrig's Disease) there exists, somewhere, the molecular needle that will pierce this therapy-resistant affliction. ...Full Article

UK Using Cognitive Computing in Personalized Medicine Push

As the pharmaceutical industry moves from the era of “blockbuster” drug discovery (developing a single drug that targets large numbers of people with a particular disease) to the era ...Full Article

Case Study: Bringing the Power of HPC to Drug Discovery and the Delivery of ‘Smarter’ Healthcare

As recently as eight years ago, the application of high performance computing (HPC) techniques to drug discovery efforts was problematic at best. Even clusters composed of 40 or 50 ...Full Article
EnterpriseAI